Seeing Is Believing
Cyteir Therapeutics's activity chart (see below) currently has 7 price targets and 9 ratings on display.
Analysts average stock forecasts to be materialized ratio is 38.1% with an average time for these price targets to be met of 81.71 days.
Most recent stock forecast was given by from BAML on 05-Jan-2024. First documented stock forecast 13-Jul-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Jan-2024
$2
$-1.02 (-33.77%)
$2
2 years 8 months 16 days ago
(05-Jan-2024)
1/3 (33.33%)
$-1.03 (-33.99%)
73
Buy Since 13-Jul-2021
$3
$-0.02 (-0.66%)
3 years 4 months 9 days ago
(12-May-2023)
1/2 (50%)
$0.6 (25.00%)
144
Sell Since 03-Feb-2023
$2
$-1.02 (-33.77%)
3 years 7 months 18 days ago
(03-Feb-2023)
1/2 (50%)
$0.31 (18.34%)
69
Hold Since 20-Jan-2023
$30
3 years 8 months 1 days ago
(20-Jan-2023)
0/1 (0%)
$10.84 (56.58%)
What is CYT (Cyteir Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CYT (Cyteir Therapeutics)?
Which analyst has the most public recommendations on CYT (Cyteir Therapeutics)?
Which analyst is the currently most bullish on CYT (Cyteir Therapeutics)?
Which analyst is the currently most reserved on CYT (Cyteir Therapeutics)?